Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
Recently, Tummino et al. reported that 34 compounds, including Chloroquine and Fluoxetine, inhibit SARS-CoV-2 replication by inducing phospholipidosis, although Chloroquine failed to suppress viral replication in Calu-3 cells and patients. In contrast, Fluoxetine represses viral replication in human...
Main Authors: | Viktoria Diesendorf, Valeria Roll, Nina Geiger, Sofie Fähr, Helena Obernolte, Katherina Sewald, Jochen Bodem |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-08-01
|
Series: | Frontiers in Cellular and Infection Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2023.1100028/full |
Similar Items
-
The Effect of Allicin on the Proteome of SARS-CoV-2 Infected Calu-3 Cells
by: Kirstin Mösbauer, et al.
Published: (2021-10-01) -
Acetylsalicylic Acid and Salicylic Acid Inhibit SARS-CoV-2 Replication in Precision-Cut Lung Slices
by: Nina Geiger, et al.
Published: (2022-09-01) -
Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis
by: A. Vejux, et al.
Published: (2008-07-01) -
Drug-induced phospholipidosis – causes, effects, identification
by: Agnieszka Katarzyna Gonet-Surówka, et al.
Published: (2023-04-01) -
Antiviral Effect of 5′-Arylchalcogeno-3-aminothymidine Derivatives in SARS-CoV-2 Infection
by: Amanda Resende Tucci, et al.
Published: (2023-09-01)